Researchers often call the polymerase chain reaction test – known as the PCR test – "the gold standard" for detecting the COVID-19 virus. The test is considered highly reliable and effective, and it ...

A new biotechnology company in McKinney has ambitions to become the world’s first fully integrated platform for polymerase chain reaction (PCR) testing — the same technology behind a common COVID-19 ...

Over the past four years, many of us have become accustomed to a swab up the nose to test for COVID-19, using at-home rapid antigen tests or the more accurate clinic-provided PCR tests with a longer ...

COLUMBUS, Ohio — You've heard a lot of talk about genomic sequencing: It's the process used in labs to detect variants of COVID-19 from PCR test samples. Some social media users falsely claim it's ...

Many people will have experienced being unwell with an unknown infection and having to undergo multiple tests to determine the culprit. This sequential process of elimination can be time-consuming and ...

COVID-19 case numbers may be plummeting, but demand for fast-acting and easily accessible PCR-quality diagnostics—for the coronavirus and beyond—shows no sign of slowing down. Ready to meet that ...

(Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that the Japan Patent ...

Co-Diagnostics’ Co-Dx PCR Platform Technologies receives Japanese Patent: Salt Lake City Friday, March 13, 2026, 15:00 Hrs [IST] Co-Diagnostics, Inc., (Co-Dx), a molecular diagn ...